Jost Fischer - 14 Aug 2023 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
Director
Signature
/s/ Alexander Wilson, Attorney-in-Fact
Issuer symbol
AEON
Transactions as of
14 Aug 2023
Net transactions value
$0
Form type
4
Filing time
16 Aug 2023, 16:06:04 UTC
Previous filing
24 Jul 2023
Next filing
21 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Stock Option Award $0 +58,851 $0.000000 58,851 14 Aug 2023 Common Stock 58,851 $5.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of stock options on August 14, 2023, which vests in 3 yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date.